Skip to Main content Skip to Navigation
Journal articles

TNF-related apoptosis-inducing ligand: signalling of a 'smart' molecule.

Abstract : Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) is a member of the tumor necrosis factor super-family and signals via two death receptors, TRAIL-R1 and TRAIL-R2, and two decoy receptors, TRAIL-R3 and TRAIL-R4, differently expressed in normal and cancer cells. TRAIL is mainly studied for its capacity to induce apoptosis preferentially in cancer cells. TRAIL is expressed in a variety of human tissues, in particular in the lymphoid system, suggesting a strong physiological role in the innate immunity. This review will focus on TRAIL gene structure and regulation, protein folding, tissue expression and molecular signalling. Finally, the potential use of TRAIL as anticancer treatment alone or in combination therapy as well as the use of drugs which signal via TRAIL and its receptors will be analyzed.
Document type :
Journal articles
Complete list of metadatas

https://www.hal.inserm.fr/inserm-00370142
Contributor : Maité Peney <>
Submitted on : Monday, March 23, 2009 - 4:23:02 PM
Last modification on : Thursday, April 23, 2020 - 2:26:26 PM

Identifiers

Collections

Citation

Fabio Manzo, Angela Nebbioso, Marco Miceli, Mariarosaria Conte, Floriana de Bellis, et al.. TNF-related apoptosis-inducing ligand: signalling of a 'smart' molecule.. International Journal of Biochemistry and Cell Biology, Elsevier, 2009, 41 (3), pp.460-6. ⟨10.1016/j.biocel.2007.12.012⟩. ⟨inserm-00370142⟩

Share

Metrics

Record views

336